相关实验视频
Updated: Jun 14, 2025

08:58
Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
Published on: March 11, 2017
15.9K
人工智能在脂肪肝疾病中的应用趋势
Tian-Ao Xie1, Li-Li Liufu2, Hui-Jin Chen3
1Department of General Surgery, Sir Run-Run Shaw Hospital, Zhejiang University, Hangzhou, 310016, China.
Hepatology international
|May 1, 2025
概括
人工智能 (AI) 为脂肪肝 (FLD) 管理提供了显著的潜力,有助于预测,诊断和治疗. 新兴的人工智能趋势侧重于先进的诊断,个性化疗法和FLD的基因分析.
科学领域:
- 医疗信息学 医疗信息学
- 计算生物学 计算生物学
- 肝病学 肝病学是一种肝病学.
背景情况:
- 人工智能 (AI) 在推进脂肪肝疾病 (FLD) 的预测,诊断,治疗和预后方面显示出巨大的前景.
- 人工智能的快速发展需要对其当前的应用和FLD研究中的未来轨迹进行全面的概述.
研究的目的:
- 系统地审查和总结人工智能在脂肪肝疾病领域的各种应用.
- 识别和突出人工智能驱动FLD研究的新兴趋势,以指导未来的科学调查.
主要方法:
- 在2006年至2024年间发表的270篇文章的图书统计分析,来自Web of Science核心收藏.
- 专注于AI在FLD中的医疗应用,分析作者,机构,国家,关键字和引用数据.
主要成果:
- 在FLD中AI的主要应用是诊断,从基本工具发展到复杂的分类和脂肪含量评估方法.
- 在FLD中AI的数据来源已经扩大到包括多样化的图像和临床数据;AI也被整合到药物开发,个性化营养和遗传研究中.
- 人工智能在预测FLD基因和利用自然语言处理 (NLP) 来获得医学见解方面越来越有用.
结论:
- 在FLD中的人工智能应用包括预测,诊断,治疗和预后,提供了超越传统医学的进步.
- 人工智能有潜力用于精准医学,远程医疗,以及在FLD管理中节约资源.
- 人工智能可以通过分析FLD预后,传统中医洞察力,基因预测和NLP来支持医疗专业人员.
关键词:
人工智能的人工智能是人工智能.计算机辅助的计算机辅助.数据可视化数据可视化诊断 诊断 诊断 诊断 诊断数字健康数字健康脂肪肝是一种脂肪肝.脂肪肝,酒精性 肝脏图像处理 图像处理医疗信息学应用程序非酒精性脂肪肝疾病是非酒精性脂肪肝疾病.精准医学是一门精准的医学.更多相关视频
相关概念视频
Ultrasound II: Endoscopic Ultrasound and FibroScan
88
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):
88
Diseases of the Liver and Gallbladder
488
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
488
Chronic Pancreatitis II: Collaborative Care
77
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
77

